Tags

Type your tag names separated by a space and hit enter

[Prevalence and correlates of anxiety and depression in patients with end-stage renal disease (ESRD)].
Z Psychosom Med Psychother. 2013; 59(2):170-88.ZP

Abstract

OBJECTIVES

Depressive symptoms are common among patients with end-stage renal disease (ESRD). They are associated with both high morbidity and high mortality. In this explorative study we investigated the frequency of Major Depression and Generalized Anxiety Disorder in a German dialysis center. We further investigated the correlation between expert-rating and self-report questionnaires as well as the extent to which somatic, dialysis-specific and sociodemographic parameters are associated with depressive and anxious symptoms.

METHOD

During dialysis treatment 52 patients (21 women and 31 men) aged 29 to 85 years with end-stage renal disease (ESRD) completed the Beck Depression Inventory (BDI) and the Hospital Anxiety and Depression Scale (HADS-D). A physician administered the Structured Clinical Interview for DSM-IV (SCID) for the expert diagnosis of Major Depression and Generalized Anxiety Disorder.

RESULTS

Nine patients met DSM-IV criteria for Major Depression (17 %). The self-report scales showed depressive symptoms in 17 patients (33 %) and 8 patients (15 %), respectively. Generalized Anxiety Disorder according to SCID was diagnosed in 9 patients (17 %), while 12 patients (23 %) scored higher than seven points on the HADS Anxiety subscale. Depressive and anxious symptoms were associated with gender, employment status, and physical activity; anxious symptoms were also associated with the body-mass-index (BMI).

CONCLUSIONS

The higher agreement between the HADS depression subscale and the SCID diagnosis of Major Depression suggests that the HADS-D depression subscale is more useful than the BDI when screening for depression in patients with ESRD. Physical activity seems to be a protective factor for patients with ESRD and should be further investigated.

Links

Publisher Full Text

Authors+Show Affiliations

Reckert A
Klinik für Psychosomatik und Psychotherapie, Universitätsklinikum Münster. anna.reckert@ukmuenster.de
Hinrichs J
No affiliation info available
Pavenstädt H
No affiliation info available
Frye B
No affiliation info available
Heuft G
No affiliation info available

MeSH

AdultAgedAged, 80 and overAnxiety DisordersComorbidityCross-Sectional StudiesDepressive Disorder, MajorFemaleGermanyHealth SurveysHemodialysis Units, HospitalHumansKidney Failure, ChronicMaleMiddle AgedPersonality InventoryRenal Dialysis

Pub Type(s)

English Abstract
Journal Article

Language

ger

PubMed ID

23775555

Citation

Reckert, Anna, et al. "[Prevalence and Correlates of Anxiety and Depression in Patients With End-stage Renal Disease (ESRD)]." Zeitschrift Fur Psychosomatische Medizin Und Psychotherapie, vol. 59, no. 2, 2013, pp. 170-88.
Reckert A, Hinrichs J, Pavenstädt H, et al. [Prevalence and correlates of anxiety and depression in patients with end-stage renal disease (ESRD)]. Z Psychosom Med Psychother. 2013;59(2):170-88.
Reckert, A., Hinrichs, J., Pavenstädt, H., Frye, B., & Heuft, G. (2013). [Prevalence and correlates of anxiety and depression in patients with end-stage renal disease (ESRD)]. Zeitschrift Fur Psychosomatische Medizin Und Psychotherapie, 59(2), 170-88.
Reckert A, et al. [Prevalence and Correlates of Anxiety and Depression in Patients With End-stage Renal Disease (ESRD)]. Z Psychosom Med Psychother. 2013;59(2):170-88. PubMed PMID: 23775555.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Prevalence and correlates of anxiety and depression in patients with end-stage renal disease (ESRD)]. AU - Reckert,Anna, AU - Hinrichs,Jens, AU - Pavenstädt,Hermann, AU - Frye,Bernhard, AU - Heuft,Gereon, PY - 2013/6/19/entrez PY - 2013/6/19/pubmed PY - 2013/8/7/medline SP - 170 EP - 88 JF - Zeitschrift fur Psychosomatische Medizin und Psychotherapie JO - Z Psychosom Med Psychother VL - 59 IS - 2 N2 - OBJECTIVES: Depressive symptoms are common among patients with end-stage renal disease (ESRD). They are associated with both high morbidity and high mortality. In this explorative study we investigated the frequency of Major Depression and Generalized Anxiety Disorder in a German dialysis center. We further investigated the correlation between expert-rating and self-report questionnaires as well as the extent to which somatic, dialysis-specific and sociodemographic parameters are associated with depressive and anxious symptoms. METHOD: During dialysis treatment 52 patients (21 women and 31 men) aged 29 to 85 years with end-stage renal disease (ESRD) completed the Beck Depression Inventory (BDI) and the Hospital Anxiety and Depression Scale (HADS-D). A physician administered the Structured Clinical Interview for DSM-IV (SCID) for the expert diagnosis of Major Depression and Generalized Anxiety Disorder. RESULTS: Nine patients met DSM-IV criteria for Major Depression (17 %). The self-report scales showed depressive symptoms in 17 patients (33 %) and 8 patients (15 %), respectively. Generalized Anxiety Disorder according to SCID was diagnosed in 9 patients (17 %), while 12 patients (23 %) scored higher than seven points on the HADS Anxiety subscale. Depressive and anxious symptoms were associated with gender, employment status, and physical activity; anxious symptoms were also associated with the body-mass-index (BMI). CONCLUSIONS: The higher agreement between the HADS depression subscale and the SCID diagnosis of Major Depression suggests that the HADS-D depression subscale is more useful than the BDI when screening for depression in patients with ESRD. Physical activity seems to be a protective factor for patients with ESRD and should be further investigated. SN - 1438-3608 UR - https://www.unboundmedicine.com/medline/citation/23775555/[Prevalence_and_correlates_of_anxiety_and_depression_in_patients_with_end_stage_renal_disease__ESRD_]_ L2 - https://www.v-r-elibrary.de/doi/10.13109/zptm.2013.59.2.170?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -